P

Prospect Venture Partners, LP

10 employees

Prospect Venture Partners is a Palo Alto, California based venture capital firm<br>with over $1B of capital under management.

Investor insights

Countries invested in

united states3

Sectors invested in

Health Care40

Biotechnology38

Pharmaceutical23

Medical Device19

Medical17

Therapeutics14

Biopharma11

medical device6

minimally invasive treatment6

radiofrequency (RF) ablation therapy6

RF Targeted Vertebral Augmentation6

Genetics5

Medical Devices3

small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease3

Test and Measurement3

Neuroscience3

Oncology3

Life Science2

Health Diagnostics2

Manufacturing2

Funding rounds participated in

$27M sweet spot round size

Most of their 75 investments are in rounds between $15M and $39M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology

Financial Services

Finance

Investments

Medical Devices

Venture Capital

Date founded

1997

Investments made

S

SentreHEART, Inc. raised $35M on September 27, 2016

Investors: Vivo Capital, Decheng Capital and Prospect Venture Partners, LP

U

Undisclosed raised $18M on April 17, 2014

Investors: -, Novo Holdings and Prospect Venture Partners, LP

E

Element Science, Inc. raised $13M on March 19, 2014

Investors: GV, Third Rock Ventures and Prospect Venture Partners, LP

N

NinePoint Medical, Inc. raised $34M on March 18, 2014

Investors: Third Rock Ventures and Prospect Venture Partners, LP

N

NGM Biopharmaceuticals raised $50M on July 18, 2013

Investors: Solon Mack Capital and Prospect Venture Partners, LP

S

SentreHEART, Inc. raised $26M on June 4, 2012

Investors: Vivo Capital and Prospect Venture Partners, LP

S

Satori Pharmaceuticals raised $15M on February 23, 2012

Investors: InterWest Partners and Prospect Venture Partners, LP

D

DFINE, Inc. raised $25M on November 8, 2011

Investors: Split Rock Partners, Vanguard Ventures, OrbiMed Advisors, HCP Ltd and Prospect Venture Partners, LP

N

NGM Biopharmaceuticals raised $55M on November 7, 2011

Investors: The Column Group, Rho Ventures and Prospect Venture Partners, LP

T

Topica Pharmaceuticals raised $27M on October 18, 2011

Investors: Third Rock Ventures, Yasuda Enteprise Development Co. Ltd and Prospect Venture Partners, LP